Catalyst Wire Dossier Catalyst Wire Dossier

Budesonide/Glycopyrronium/Formoterol Fumarate

Budesonide/glycopyrronium/formoterol fumarate · AstraZeneca
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Budesonide/Glycopyrronium/Formoterol Fumarate, covering 2025-09-19 to 2025-09-19. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Assess the Safety of Budesonide/Glycopyrronium/Formoterol Fumarate With a Next-Generation Propellant in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease [Phase 3]

See pricing